{"title":"[功能性躯体疾病的非药物干预的有效性和成本效益:荟萃分析和经济评估的系统回顾]。","authors":"Inmaculada Boluda-Verdú, Ferrán Catalá-López","doi":"10.1016/j.gaceta.2025.102457","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders through a review of systematic reviews with meta-analysis and economic evaluations.</p><p><strong>Method: </strong>Searches were carried out in PubMed/MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and PsycINFO (until June 2024). Outcome measures were improvement in symptoms (for systematic reviews) and incremental cost-effectiveness ratio (for economic evaluations). Methodological quality was assessed with AMSTAR-2 for systematic reviews and with QHES for economic evaluations. A narrative synthesis of the studies was performed, without meta-analysis.</p><p><strong>Protocol registration: </strong>Open Science Framework (https://osf.io/u3w2b/).</p><p><strong>Results: </strong>32 studies were included (27 systematic reviews and 5 economic evaluations). All systematic reviews included randomized trials, except 2 that also included non-randomized studies. In systematic reviews, the most studied conditions were gastrointestinal disorders (12/27) and physical symptoms not explained by an organic pathology (6/27), while in economic evaluations they were undifferentiated somatoform disorders (2/5). The systematic reviews that included comparisons of psychological therapies, mindfulness and herbal medicine seemed to indicate improvements in symptoms. However, those systematic reviews that included acupuncture were inconclusive. All economic evaluations were associated with randomized trials. The incremental cost-effectiveness ratios were dominant (less costs, more effective) in 2 studies evaluating cognitive behavioral therapy. Of the systematic reviews, 20 presented critically low quality, 5 low quality and 2 moderate quality, while the 5 economic evaluations presented high quality.</p><p><strong>Conclusions: </strong>The evidence on the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders should be interpreted with caution since the majority of the systematic reviews were of low or critically low methodological quality, and with a high level of uncertainty in the case of economic evaluations. The diversity of definitions of the diagnosis and interventions makes it difficult to generalize these results.</p>","PeriodicalId":94017,"journal":{"name":"Gaceta sanitaria","volume":" ","pages":"102457"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders: systematic review of meta-analyses and economic evaluations].\",\"authors\":\"Inmaculada Boluda-Verdú, Ferrán Catalá-López\",\"doi\":\"10.1016/j.gaceta.2025.102457\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To analyze the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders through a review of systematic reviews with meta-analysis and economic evaluations.</p><p><strong>Method: </strong>Searches were carried out in PubMed/MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and PsycINFO (until June 2024). Outcome measures were improvement in symptoms (for systematic reviews) and incremental cost-effectiveness ratio (for economic evaluations). Methodological quality was assessed with AMSTAR-2 for systematic reviews and with QHES for economic evaluations. A narrative synthesis of the studies was performed, without meta-analysis.</p><p><strong>Protocol registration: </strong>Open Science Framework (https://osf.io/u3w2b/).</p><p><strong>Results: </strong>32 studies were included (27 systematic reviews and 5 economic evaluations). All systematic reviews included randomized trials, except 2 that also included non-randomized studies. In systematic reviews, the most studied conditions were gastrointestinal disorders (12/27) and physical symptoms not explained by an organic pathology (6/27), while in economic evaluations they were undifferentiated somatoform disorders (2/5). The systematic reviews that included comparisons of psychological therapies, mindfulness and herbal medicine seemed to indicate improvements in symptoms. However, those systematic reviews that included acupuncture were inconclusive. All economic evaluations were associated with randomized trials. The incremental cost-effectiveness ratios were dominant (less costs, more effective) in 2 studies evaluating cognitive behavioral therapy. Of the systematic reviews, 20 presented critically low quality, 5 low quality and 2 moderate quality, while the 5 economic evaluations presented high quality.</p><p><strong>Conclusions: </strong>The evidence on the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders should be interpreted with caution since the majority of the systematic reviews were of low or critically low methodological quality, and with a high level of uncertainty in the case of economic evaluations. The diversity of definitions of the diagnosis and interventions makes it difficult to generalize these results.</p>\",\"PeriodicalId\":94017,\"journal\":{\"name\":\"Gaceta sanitaria\",\"volume\":\" \",\"pages\":\"102457\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-03-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gaceta sanitaria\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.gaceta.2025.102457\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gaceta sanitaria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.gaceta.2025.102457","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:通过荟萃分析和经济评价的系统综述,分析非药物干预治疗功能性躯体疾病的有效性和成本效益。方法:检索PubMed/MEDLINE、EMBASE、Cochrane Database of Systematic Reviews和PsycINFO(截止至2024年6月)。结果指标为症状改善(用于系统评价)和增量成本-效果比(用于经济评价)。方法质量通过AMSTAR-2进行系统评价,QHES进行经济评价。对研究进行叙事综合,不进行meta分析。协议注册:开放科学框架(https://osf.io/u3w2b/)。结果:纳入32项研究(27项系统评价和5项经济评价)。除2项纳入非随机研究外,所有系统评价均纳入随机试验。在系统评价中,研究最多的疾病是胃肠道疾病(12/27)和不能用器质性病理解释的身体症状(6/27),而在经济学评价中,它们是未分化的躯体形式疾病(2/5)。包括心理疗法、正念和草药的比较在内的系统综述似乎表明症状有所改善。然而,那些包括针灸在内的系统评价是不确定的。所有经济评价均与随机试验相关。在2项评估认知行为疗法的研究中,增量成本-效果比占主导地位(成本更低,效果更佳)。系统评价中,极低质量评价20篇,低质量评价5篇,中等质量评价2篇,高质量评价5篇。结论:关于功能性躯体疾病的非药物干预的有效性和成本效益的证据应谨慎解释,因为大多数系统评价的方法学质量较低或极低,并且在经济评估的情况下具有很高的不确定性。诊断和干预定义的多样性使得很难概括这些结果。
[Effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders: systematic review of meta-analyses and economic evaluations].
Objective: To analyze the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders through a review of systematic reviews with meta-analysis and economic evaluations.
Method: Searches were carried out in PubMed/MEDLINE, EMBASE, Cochrane Database of Systematic Reviews and PsycINFO (until June 2024). Outcome measures were improvement in symptoms (for systematic reviews) and incremental cost-effectiveness ratio (for economic evaluations). Methodological quality was assessed with AMSTAR-2 for systematic reviews and with QHES for economic evaluations. A narrative synthesis of the studies was performed, without meta-analysis.
Protocol registration: Open Science Framework (https://osf.io/u3w2b/).
Results: 32 studies were included (27 systematic reviews and 5 economic evaluations). All systematic reviews included randomized trials, except 2 that also included non-randomized studies. In systematic reviews, the most studied conditions were gastrointestinal disorders (12/27) and physical symptoms not explained by an organic pathology (6/27), while in economic evaluations they were undifferentiated somatoform disorders (2/5). The systematic reviews that included comparisons of psychological therapies, mindfulness and herbal medicine seemed to indicate improvements in symptoms. However, those systematic reviews that included acupuncture were inconclusive. All economic evaluations were associated with randomized trials. The incremental cost-effectiveness ratios were dominant (less costs, more effective) in 2 studies evaluating cognitive behavioral therapy. Of the systematic reviews, 20 presented critically low quality, 5 low quality and 2 moderate quality, while the 5 economic evaluations presented high quality.
Conclusions: The evidence on the effectiveness and cost-effectiveness of non-pharmacological interventions for functional somatic disorders should be interpreted with caution since the majority of the systematic reviews were of low or critically low methodological quality, and with a high level of uncertainty in the case of economic evaluations. The diversity of definitions of the diagnosis and interventions makes it difficult to generalize these results.